Pfizer Inc. (FRA:PFE)
21.90
+0.81 (3.84%)
Nov 11, 2025, 9:17 PM CET
Pfizer Revenue
Pfizer had revenue of $16.65B USD in the quarter ending September 28, 2025, a decrease of -5.92%. This brings the company's revenue in the last twelve months to $62.79B, up 3.89% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.79B
Revenue Growth
+3.89%
P/S Ratio
2.24
Revenue / Employee
$775.12K
Employees
81,000
Market Cap
120.04B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Pfizer News
- 5 hours ago - Markets exhale as Novo Nordisk withdraws from Metsera bidding war - Euronews
- 9 hours ago - Metsera: Why Pfizer And Novo Nordisk Fought Hard Over This Obesity Drug Developer - Seeking Alpha
- 9 hours ago - PFE a Top 25 Dividend Giant With $19.76B Held By ETFs - Nasdaq
- 12 hours ago - Why a Strong Quarter Wasn't Enough to Send Shares of Pfizer Soaring - The Motley Fool
- 13 hours ago - Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology Transcript - Seeking Alpha
- 19 hours ago - Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology - Slideshow - Seeking Alpha
- 1 day ago - FDA Approves Generic Version of Pfizer's (PFE) Premarin Amid Label Changes - GuruFocus
- 1 day ago - PFE: FDA Updates Hormone Replacement Therapy Warnings - GuruFocus